Lv1
10 积分 2024-06-04 加入
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
5天前
已完结
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
5天前
已完结
A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test
18天前
已完结
Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer
2个月前
已完结
ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification
6个月前
已完结
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma
7个月前
已完结
The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy
7个月前
已完结
Leveraging the pleural space for anticancer therapies in pleural mesothelioma
7个月前
已完结
Unleashing precision: a review of targeted approaches in pleural mesothelioma
7个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
8个月前
已完结
皖公网安备34019202002308
